register

Medical

Children’s cancer researcher awarded NSW Premier’s Woman of the Year

Health Industry Hub | March 9, 2020 |

Professor Kavallaris was announced as the 2020 NSW Premier’s Woman of the Year at a ceremony in Sydney.  She is Head of Translational Cancer Nanomedicine at Children’s Cancer Institute and Founding Director of the Australian Centre for NanoMedicine at UNSW Sydney.

The prestigious award recognises NSW women who have excelled in their chosen career, field or passion; are exceptional achievers who have made a significant contribution to NSW and whose accomplishments make them a strong role model for other women.

“I am truly honoured to have received this award and I hope it inspires young women to do what they love, grow and learn, and to lead with generosity and respect,” Professor Kavallaris said.

Professor Kavallaris is internationally renowned for her research in cancer biology and therapeutics. She has been widely recognised for the innovation and impact of her research, her leadership as well as her mentoring of talented young scientists. She is passionate about training the next generation of research leaders.

Enhance corporate branding and boost thought leadership to attract and retain quality employees. How does your company culture and digital footprint measure up in the Australian Pharma or Biotech industry? Get the benchmark report by contacting us.

Maria’s personal journey with cancer began at the age of 21 and has driven her research to develop effective and less toxic cancer treatments. 

As one of the original three scientists appointed at Children’s Cancer Institute when its laboratories first opened in 1984, she has made important discoveries in relation to the mechanisms of clinical drug resistance and tumour aggressiveness in childhood cancer.

Her studies have not only identified how some tumours can grow and spread, she has also applied this knowledge to develop effective, less toxic cancer therapies using nanotechnology.

“To be able to make a difference to the lives of children with cancer and their families by developing better treatments and improving survival rates is very humbling. Even if you can save one child’s life, that’s an incredible feat,” Professor Kavallaris said.

As a conjoint professor in the UNSW Faculty of Medicine, Professor Kavallaris relishes her role of mentor and has supervised many Honours and PhD students, several whom have gone on to become research leaders.

Professor Kavallaris’s extensive research and leadership contributions have been recognised by numerous awards including the NSW Premier’s Prize for Science and Engineering (Leadership in Innovation in NSW) in 2017, the Australian Society for Biochemistry and Molecular Biology’s Lemberg Medal in 2019 and she was named as a Member of the Order of Australia (AM) for ‘significant service to medicine, and to medical research, in the field of childhood and adult cancers’ on Australia Day 2019.

Register FREE to receive the latest industry news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


News & Trends - MedTech & Diagnostics

Medtronic partners with local researchers in stroke trial

Medtronic partners with local researchers in stroke trial

Health Industry Hub | March 1, 2024 |

MedTech & Diagnostics News: Endovascular thrombectomy has been shown to be more effective in reducing disability than medical therapy alone […]

More


News & Trends - Pharmaceuticals

Health Ministers reflect on the reforms and complexities facing the healthcare system

Health Ministers reflect on the reforms and complexities facing the healthcare system

Health Industry Hub | March 1, 2024 |

Pharma News: Mark Butler MP, Federal Minister for Health, and Senator Anne Ruston, Shadow Minister for Health, reflected on the […]

More


News & Trends - Pharmaceuticals

Gilead seeks funding of CAR T-cell therapy in follicular lymphoma

Gilead seeks funding of CAR T-cell therapy in follicular lymphoma

Health Industry Hub | March 1, 2024 |

Pharma News: Gilead has applied to the Medical Services Advisory Committee (MSAC) for funding of its cutting-edge CAR T-cell therapy, […]

More


News & Trends - MedTech & Diagnostics

Should private insurers face scrutiny for soaring profits while patients foot the bill? MTAA, Private Healthcare Australia

Should private health insurers face scrutiny for soaring profits while patients foot the bill?

Health Industry Hub | March 1, 2024 |

MedTech & Diagnostics News: In a clash of interests, the Medical Technology Association of Australia (MTAA) has once again urged […]

More


This content is copyright protected. Please subscribe to gain access.